Atrial fibrillation is common, affecting approximately 5.2 million patients in 2010 in the United States, and this is projected to increase to 12.1 million in 2030. Tanvi Patil Stacey Zysk Kezia ...

Dofetilide is a class III antiarrhythmic drug that is used for maintenance of sinus rhythm in patients with atrial fibrillation. Dofetilide blocks potassium channels in phase 3 of the action potential ...

Harper University Hospital, a 600-bed facility, is the largest of the seven hospitals of the Detroit Medical Center (DMC). It serves as a teaching and clinical research site for Wayne State University ...

For dofetilide to be available at any institution, three FDA requirements must be fulfilled. First, the institution must complete a staff education process and submit an Education Confirmation Form ...